The consultants' coverage of the IVD Diabetes Monitoring market includes close tracking of WBG monitoring, HbA1c testing, and Diabetes Urine Dipstick (DUD) testing. WBG monitoring constitutes the largest proportion of the worldwide IVD Diabetes Monitoring market, accounting for >90% of sales. Further, the consultants follow competitive developments in all areas of the IVD Diabetes Monitoring market.
Whole Blood Glucose (WBG) Monitoring Market
End-User Segments
More than 75% of the worldwide WBG Monitoring market is generated through sales to the consumer for Patient Self-Testing (PST), making the market dynamics unique compared to those in the remainder of the laboratory-focused IVD industry. Over the past several years, WBG monitoring products have become increasingly segmented with product features designed to address specific end-user needs, including connectivity-ready WBG monitoring systems for POCT (in developed country markets), WBG monitoring products dedicated for use in LTC settings, and traditional products designed for PST.
The "Top Four" competitors in the worldwide WBG Monitoring market are:
Secondary competitors, which combined account for approximately 10% to 12% of the worldwide WBG Monitoring market, include but are not limited to:
In addition to the above-mentioned competitors, the consultants closely follow smaller participants with low-cost product offerings and emerging competitors with disruptive technologies (including non-invasive testing).
Given the recent industry trend of related diversification and the integration of WBG monitoring technologies with insulin infusion pump therapies, the consultants also maintain careful surveillance of several insulin infusion pump competitors, including:
Market expansion is occurring through the introduction of the first continuous glucose monitoring technologies. Current participants include Medtronic MiniMed and DexCom, but the market is expected to see additional entrants in the near-term/long-term future. The consultants are familiar with a broad spectrum of ongoing development efforts in the area of continuous glucose monitoring and closely monitor advancements in this field.
Market Assessment/Monitoring Reports:
Relevant Conferences: